Russia gives cross country mask necessity in the midst of fast COVID-19 resurgence Kumar Jeetendra | October 27, 2020 Health authorities enrolled 16,550 new instances and 320 new deaths on Tuesday, the greatest daily death toll since the beginning of the pandemic. Russia’s public health agency, Rospotrebnadzor, ordered all Russians to wear masks in crowded public areas, on public transport, in taxis, at parking lots and in elevators starting on Wednesday. The agency also …
Pfizer not yet prepared to deliver COVID-19 vaccine data Kumar Jeetendra | October 27, 2020 Drugmaker Pfizer Inc said on October 27 that it wasn’t yet ready to release data in the late-stage trial of the COVID-19 vaccine candidate it is growing with Germany’s BioNTech SE. Pfizer’s CEO Albert Bourla has said the company could release data on whether or not the vaccine works as early as this month, but …
Omega-3 rich nourishments improve forecast in patients with myocardial dead tissue Kumar Jeetendra | October 27, 2020 A team of researchers from the Germans Trias I Pujol Hospital and Research Institute (IGTP) and the Hospital del Mar Medical Research Institute (IMIM) has shown that regularly consuming foods full of omega-3 fatty acids, from the animal and vegetable roots, strengthens the heart’s membranes and helps improve the prognosis in the event of a …
Study recognizes 17 new genes that could be focused for treatment of psoriasis, dermatitis Kumar Jeetendra | October 27, 2020 A Swedish study has identified 17 new genes which could be targeted for therapy of psoriasis and eczema, two frequent hereditary skin diseases with no cure. Pelin Sahlén, senior lecturer in KTH Royal Institute of Technology, says the joint KTH-Karolinska Institutet research team mapped 118 gene targets regarding the skin ailments, psoriasis and atopic dermatitis, …
GSK, Sanofi to make 200 million doses accessible for COVID-19 antibody union Kumar Jeetendra | October 28, 2020 French drugmaker Sanofi SA and Britain’s GlaxoSmithKline plan to create 200 million doses of the COVID-19 vaccine candidate accessible to the vaccine allocation program co-led by GAVI and the World Health Organization. The companies said on October 28 they have signed a statement of intent with vaccine alliance GAVI, which is coordinating the global plan …
Stewart Kay joins Adaptate Biotherapeutics as Chief Business Officer Kumar Jeetendra | October 28, 2020 In this new role, Stewart will work as part of the Executive staff to drive Adaptate’s Business and Corporate Development activities. Stewart Kay, CBO, Adaptate Biotherapeutics Adaptate is developing a range of therapeutic antibodies that recognize drug targets and have the potential to modulate the activity of gamma delta T cells. Gamma delta T cells …
Myeloid cells can smother insusceptible reaction, advance cerebrum metastasis Kumar Jeetendra | October 28, 2020 Scientists have long thought that the brain protects itself from an aggressive immune response to keep inflammation down. However, that evolutionary management may work against it when a cancer cell tries to spread to the brain, researchers at the University of Notre Dame have found. In recently published research in the journal Cell, researchers showed …
Cipla launches ‘ELIFast’ (IgG ELISA test) for COVID-19 antibody detection Kumar Jeetendra | October 28, 2020 Mumbai, India; October 28, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla,” today announced the commercialisation of antibody detection kits for COVID-19 in India. In partnership with KARWA Ltd. under the technology transfer from the Indian Council of Medical Research (ICMR). As part of this collaborative effort, Cipla will be responsible …
Next harvest of COVID-19 immunization designers take more customary route Kumar Jeetendra | October 29, 2020 The handful of drugmakers dominating the global coronavirus vaccine race are pushing the bounds of vaccine technology. The following crop under development feature more traditional, proven designs. The world will need several different vaccines to fight the COVID-19 pandemic, given the sheer size of international need, variations in effects on various populations, and possible limits …
First arrangement of COVID-19 antibodies liable to be ‘defective’, cautions UK master Kumar Jeetendra | October 29, 2020 The first set of COVID-19 vaccines that clear clinical trials for rollout to combat the deadly virus are most likely to be imperfect and might not work equally for everyone, the chief of the United Kingdom government’s Vaccine Taskforce has warned. Kate Bingham, Chair of the UK’s Vaccine Taskforce set up earlier this year to …
Cell scientists and bioimaging master collaborate to settle fourth measurement insider facts Kumar Jeetendra | October 29, 2020 Cell biologists at the University of Illinois in Urbana-Champaign and Bar-Ilan University in Israel and a bioimaging expert at the University of Central Florida are teaming up in what they expect may result in a major breakthrough in the understanding of the three-dimensional organization of the nucleus over their role in certain diseases. The dream …
Microfluidizer Enables Scalable Production of High Conductivity Carbon Nanotubes Kumar Jeetendra | October 29, 2020 Analytik reports on pioneering work undertaken by Professor Welland’s group at the Nanoscience Centre in the Department of Engineering at the University of Cambridge (UK) using a LM20 Microfluidizer to help produce high conductivity carbon nanotube films. Carbon nanotubes are amazing conductive materials that are very strong, flexible, and chemically stable. Their large-scale industrial adoption …
